JCR Pharmaceuticals (JCRRF) Short Interest Ratio & Short Volume $4.57 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest JCR Pharmaceuticals Short Interest DataJCR Pharmaceuticals (JCRRF) has a short interest of 459,300 shares. This marks a -9.05% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 200 shares to cover all short positions.Current Short Interest459,300 sharesPrevious Short Interest505,000 sharesChange Vs. Previous Month-9.05%Dollar Volume Sold Short$2.10 millionShort Interest Ratio0.0 Days to CoverLast Record DateDecember 31, 2024Today's Trading Volume0 sharesAverage Trading Volume200 sharesToday's Volume Vs. Average0% Short Selling JCR Pharmaceuticals? Sign up to receive the latest short interest report for JCR Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartJCRRF Short Interest Over TimeJCRRF Days to Cover Over TimeJCRRF Percentage of Float Shorted Over Time JCR Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2024459,300 shares $2.10 million -9.1%N/A0 $4.57 12/15/2024505,000 shares $2.31 million +5.9%N/A0 $4.57 11/30/2024477,000 shares $2.18 million +16.7%N/A0 $4.57 11/15/2024408,600 shares $1.87 million +40.8%N/A0 $4.57 10/31/2024290,200 shares $1.33 million -4.9%N/A0 $4.57 10/15/2024305,200 shares $1.39 million +1.4%N/A3052 $4.57 9/30/2024301,000 shares $1.41 million +0.2%N/A0 $4.70 9/15/2024300,300 shares $1.41 million -3.0%N/A3003 $4.70 8/31/2024309,700 shares $1.33 million -12.1%N/A0 $4.30 8/15/2024352,400 shares $1.52 million -7.3%N/A0 $4.30 Get the Latest News and Ratings for JCRRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for JCR Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024380,200 shares $1.64 million -6.1%N/A3802 $4.30 7/15/2024405,000 shares $2.11 million -21.8%N/A0 $5.22 6/30/2024517,600 shares $2.70 million +15.8%N/A0 $5.22 6/15/2024447,000 shares $2.33 million -17.8%N/A0 $5.22 5/31/2024544,000 shares $2.84 million +0.8%N/A0 $5.22 5/15/2024539,500 shares $2.82 million +5.3%N/A0 $5.22 4/30/2024512,400 shares $2.67 million -7.0%N/A0 $5.22 4/15/2024551,200 shares $2.88 million -6.7%N/A5512 $5.22 3/31/2024590,800 shares $3.66 million -6.0%N/A0 $6.20 3/15/2024628,800 shares $3.90 million -20.6%N/A0 $6.20 2/29/2024791,700 shares $4.91 million -2.7%N/A0 $6.20 2/15/2024813,800 shares $5.05 million +5.5%N/A8138 $6.20 1/15/2024726,700 shares $6.57 million -3.3%N/A0 $9.04 12/31/2023751,100 shares $6.79 million -0.1%N/A0 $9.04 12/15/2023752,000 shares $6.80 million -3.2%N/A0 $9.04 11/30/2023776,700 shares $7.02 million -5.1%N/A0 $9.04 11/15/2023818,200 shares $7.40 million +0.2%N/A0 $9.04 10/31/2023816,300 shares $7.38 million +0.6%N/A0 $9.04 10/15/2023811,100 shares $7.33 million -1.1%N/A8111 $9.04 9/30/2023820,000 shares $8.29 million -5.8%N/A8200 $10.11 9/15/2023870,600 shares $8.24 million +3.7%N/A0 $9.47 8/31/2023839,900 shares $7.95 million -1.6%N/A0 $9.47 8/15/2023853,300 shares $8.08 million -4.8%N/A0 $9.47 7/31/2023896,300 shares $8.49 million +20.9%N/A8963 $9.47 7/15/2023741,600 shares $7.04 million +13.4%N/A0 $9.49 6/30/2023654,100 shares $6.21 million -2.9%N/A6541 $9.49 6/15/2023673,300 shares $7.24 million +9.4%N/A0 $10.76 5/31/2023615,400 shares $6.62 million +53.9%N/A0 $10.76 5/15/2023400,000 shares $4.30 million +11.6%N/A0 $10.76 4/30/2023358,500 shares $3.86 million +17.5%N/A0 $10.76A deadly mistake in my prediction… (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 4/15/2023305,000 shares $3.28 million +8.2%N/A3050 $10.76 3/31/2023281,800 shares $2.93 million +4.3%N/A2818 $10.40 3/15/2023270,200 shares $2.81 million -5.4%N/A2702 $10.40 2/28/2023285,700 shares $3.54 million -0.2%N/A0 $12.38 2/15/2023286,300 shares $3.54 million -10.5%N/A1431.5 $12.38 1/31/2023319,700 shares $6.15 million +11.4%N/A0 $19.24 1/15/2023287,100 shares $5.52 million -13.1%N/A0 $19.24 12/30/2022330,400 shares $6.36 million -5.9%N/A3304 $19.24 12/15/2022351,100 shares $6.76 million -65.0%N/A1.1 $19.24 11/30/20221,004,100 shares $19.32 million +120.8%N/A0 $19.24 11/15/2022454,800 shares $8.75 million +14.6%N/A0 $19.24 10/31/2022397,000 shares $7.64 million +3.9%N/A0 $19.24 10/15/2022382,200 shares $7.35 million +1.0%N/A3822 $19.24 9/30/2022378,300 shares $7.28 million +0.3%N/A3783 $19.24 9/15/2022377,200 shares $7.26 million -63.3%N/A1.3 $19.24 8/31/20221,027,200 shares $19.76 million +22.5%N/A0 $19.24 8/15/2022838,500 shares $16.13 million +39.5%N/A8385 $19.24 7/31/2022601,000 shares $11.56 million -34.2%N/A751.3 $19.24 7/15/2022912,800 shares $16.38 million +91.5%N/A0 $17.95 6/30/2022476,600 shares $8.55 million +2.1%N/A0 $17.95 6/15/2022466,800 shares $8.38 million +0.5%N/A0 $17.95 5/31/2022464,400 shares $8.34 million -8.5%N/A0 $17.95 5/15/2022507,600 shares $9.11 million -1.8%N/A0 $17.95 4/30/2022517,100 shares $9.28 million +3.8%N/A0 $17.95 4/15/2022498,400 shares $8.95 million +3.4%N/A0 $17.95 3/31/2022482,000 shares $8.65 million -14.4%N/A0 $17.95 3/15/2022563,300 shares $10.11 million -26.9%N/A0 $17.95 2/28/2022771,000 shares $13.84 million +3.4%N/A0 $17.95 2/15/2022745,500 shares $13.38 million +1.0%N/A0 $17.95 1/31/2022738,500 shares $13.26 million -23.6%N/A2461.7 $17.95 1/15/2022967,100 shares $26.98 million +43.5%N/A0 $27.90 12/31/2021674,100 shares $18.81 million +25.1%N/A0 $27.90 12/15/2021538,700 shares $15.03 million +16.6%N/A0 $27.90 11/30/2021462,000 shares $12.89 million -1.6%N/A0 $27.90 11/15/2021469,400 shares $13.10 million +11.4%N/A0 $27.90 10/29/2021421,500 shares $11.76 million -4.8%N/A0 $27.90 10/15/2021442,800 shares $12.35 million -1.3%N/A0 $27.90 9/30/2021448,400 shares $12.51 million -18.4%N/A0 $27.90 9/15/2021549,600 shares $15.33 million -36.9%N/A5496 $27.90 8/31/2021871,500 shares $24.31 million +22.7%N/A0 $27.90 8/13/2021710,100 shares $19.81 million +57.9%N/A0 $27.90 7/30/2021449,800 shares $12.55 million -7.2%N/A0 $27.90 7/15/2021484,600 shares $13.52 million -1.8%N/A0 $27.90 6/30/2021493,300 shares $13.76 million +0.7%N/A0 $27.90 6/15/2021490,100 shares $13.67 million +1.9%N/A0 $27.90 5/28/2021481,000 shares $13.42 million +16.6%N/A0 $27.90 5/14/2021412,700 shares $11.51 million -7.2%N/A0 $27.90 4/30/2021444,500 shares $12.40 million -22.4%N/A4445 $27.90 4/15/2021573,100 shares $19.40 million +51.4%N/A0 $33.85 3/31/2021378,500 shares $12.81 million +42.0%N/A0 $33.85A deadly mistake in my prediction… (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 3/15/2021266,500 shares $9.02 million +27.6%N/A0 $33.85 2/26/2021208,900 shares $7.07 million +25.4%N/A2089 $33.85 2/12/2021166,600 shares $0.00 -33.6%N/A0 $0.00 1/29/2021251,000 shares $0.00 +48.9%N/A0 $0.00 1/15/2021196,800 shares $0.00 +37.4%N/A0 $0.00 12/31/2020125,700 shares $0.00 -36.1%N/A0 $0.00 JCRRF Short Interest - Frequently Asked Questions What is JCR Pharmaceuticals' current short interest? Short interest is the volume of JCR Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 459,300 shares of JCRRF short. Learn More on JCR Pharmaceuticals' current short interest. Is JCR Pharmaceuticals' short interest increasing or decreasing? JCR Pharmaceuticals saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 459,300 shares, a drop of 9.0% from the previous total of 505,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does JCR Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to JCR Pharmaceuticals: Daiichi Sankyo Company, Limited (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short JCR Pharmaceuticals stock? Short selling JCRRF is an investing strategy that aims to generate trading profit from JCR Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against JCR Pharmaceuticals? A short squeeze for JCR Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JCRRF, which in turn drives the price of the stock up even further. How often is JCR Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JCRRF, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies AZNCF Short Squeeze CSPCY Short Squeeze KYKOF Short Squeeze MAYNF Short Squeeze OPHLY Short Squeeze ORINF Short Squeeze OTSKY Short Squeeze OTSKF Short Squeeze RHHVF Short Squeeze SNYNF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:JCRRF) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JCR Pharmaceuticals Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share JCR Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JCRRF Stock Alerts